2) Copaxone (glatiramer acetate) Copaxone is used to treat MS, specifically relapsing forms of multiple sclerosis to reduce the frequency of relapses
While these medications don't selectively target belly fat, clinical trials demonstrate meaningful decreases in visceral adipose tissuethe metabolically harmful fat surrounding internal organsas part of overall fat loss
The retraction adds another layer of uncertainty
27 This is a double-blind placebo-controlled study testing the safety and efficacy of ALC compared to placebo in the treatment of pain in HIV-positive patients with distal symmetric polyneuropathy related to antiretroviral drugs
Zheng, H., Wang, Y., Zhu, J., Yao, Y., Zhang, C., & Gao, Q
PubMed laboratory research record [PMID: 3752189] PubMed record related to this compound for laboratory literature review